Data have been presented that CD8+CD28−CD56− T cells have suppressive activity in rheumatoid arthritis (RA), preventing the activation of naïve CD4+ T cells and inhibiting their effector function in vivo. Here, CD8A is linked to rheumatoid arthritis.